Cardiometabolic diseases are leading causes of ill health, and neighbourhoods that support everyday walking may help reduce them. Studies often report lower disease prevalence in more walkable neighbourhoods. However, because walkability operates across multiple spatial scales, city-wide associations may conflate local neighbourhood form with broader metropolitan structure and co-varying environmental exposures. Here we show that while much of the walkability--morbidity association in Greater London operates through the city's macro-scale spatial structure, local alignment persists beyond it. Using an open five-component walkability index for 4,994 London census units and recorded prevalence of eight cardiometabolic conditions from primary-care registers, we found that higher walkability was inversely associated with all eight outcomes after adjusting for demographic composition and deprivation; one standard deviation higher walkability corresponded to 1.43 percentage points lower hypertension prevalence. Walkability followed a centre--periphery gradient, with a radial model explaining 74.2\% of its variation. Coefficients were reduced by 2--43\% within boroughs and 11--75\% after centre--periphery adjustment. After spatial-error adjustment, no clear association remained for obesity; coefficients for the other seven were reduced by 83--99\% relative to comparable log-scale models. Nevertheless, observed associations were more extreme than those from surrogate walkability surfaces preserving this spatial structure, for all eight outcomes in the primary analyses and for five after adjustment for nitrogen oxides. These findings caution against interpreting city-wide walkability coefficients as neighbourhood effects independent of wider metropolitan structure, and highlight the need for studies of neighbourhood form and health to disentangle global and local spatial structure explicitly.
Objective: To examine how changes in clinical measurement practices affect the transportability of predictive information from physiological trajectories and observation patterns in longitudinal ICU records. Methods: In-hospital mortality was predicted using measurements from the first 48 hours of ICU admission in MIMIC-III, MIMIC-IV, and eICU. Nested representations captured the latest physiological state (R1), trajectory summaries (R2), and observation timing and frequency (R3). Models trained on 7,762 MetaVision patients were evaluated on 21,682 MIMIC-IV and 43,878 eICU patients from 204 hospitals. Restriction experiments tested measurement timing at matched counts and reduced availability. Results: Physiological trajectories improved prediction beyond latest values across settings, including transfer to eICU (R2-R1 log-loss difference -0.01446, 95% CI -0.01701 to -0.01202). Observation patterns improved prediction following transfer to MIMIC-IV (R3-R2 -0.00564) and in locally developed eICU models (-0.00402, 95% CI -0.00517 to -0.00283), but not clearly following transfer from MetaVision to eICU (+0.00106, 95% CI -0.00087 to +0.00355). At matched observation counts, retaining measurements spread throughout the 48-hour window reduced log loss relative to random retention, more for R3 than R2 (0.04324 versus 0.00721). R3 was also more sensitive to the loss of recent measurements. Retraining under reduced availability restored its advantage over R2. Conclusions: Physiological trajectories transferred consistently, while observation patterns offered less reliable benefits and greater sensitivity to measurement timing and availability. Their transferability may depend on diversity of measurement practices during training. Clinical prediction models should be evaluated across measurement conditions as well as patient populations.